BEVRA HAHN, M.D.
PROFESSOR OF MEDICINE; CHIEF, DIVISION OF RHEUMATOLOGY; DEPT. OF MEDICINE
DAVID GEFFEN SCHOOL OF MEDICINE, UCLA
MODERATOR: PENG FAN, M.D.; MEMBER, MEDICAL EDUCATION COMMITTEE, PSJMC
FACULTY DISCLOSURE:According to CMA guidelines for faculty disclosure of commercial support, we are required to announce the following:
Dr. Hahn states she is a consultant for Biogen IDEC, Bristol Myers Squibb and Idera Pharmaceuticals, is a grant recipient from Aspreva, and is on the Data Safety Monitoring Board for Bristol Myers Squibb.
OBJECTIVES
At the end of the presentation, attendees will be able to:
- discuss current thoughts regarding pathogenesis of SLE
- recognize the signs and symptoms of SLE, conduct an appropriate work-up, and make the diagnosis
- incorporate current therapeutic approaches to SLE
- identify cultural/linguistic factors that impact the epidemiology, incidence, diagnosis, treatment, clinical course, and/or long-term outcomes of SLE